Form 4: Clene Inc. Director Ugwumba Acquires Warrants
SEC Form 4 Filing
Director Chidozie Ugwumba reports acquisition of warrants in Clene Inc. through Symbiosis II, LLC.
Summary
- Chidozie Ugwumba, a director of Clene Inc., filed a Form 4 disclosing changes in beneficial ownership.
- The report details the acquisition of warrants to purchase Clene Inc. common stock.
- On September 30, 2024, Ugwumba acquired 424,358 warrants with an exercise price of $4.82 and 424,358 prefunded warrants with an exercise price of $4.712.
- These warrants were acquired indirectly through Symbiosis II, LLC.
- The warrants became exercisable on October 1, 2024, with the $4.82 warrants expiring on October 1, 2029, while the prefunded warrants have no expiration date.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports a transaction.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders such as directors or officers trade in their company's stock. This filing indicates Ugwumba's increased investment in Clene Inc.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of warrant acquisition |
| 10/01/2024 | Date warrants become exercisable |
| 10/01/2029 | Expiration date of $4.82 warrants |
| 10/02/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.